Loading organization details...
Loading organization details...
Source: IRS Form 990 via ProPublica Nonprofit Explorer
Total Revenue
▼$559.3K
Total Contributions
$63K
Total Expenses
▼$495.2K
Total Assets
$350.1K
Total Liabilities
▼$0
Net Assets
$350.1K
Officer Compensation
→$0
Other Salaries
$0
Investment Income
▼$2,331
Fundraising
▼$0
Source: USAspending.gov · Searched by organization name
Total Federal Funding
$12K
Awards Found
2
| Awarding Agency | Description | Amount | Fiscal Year | Period |
|---|---|---|---|---|
| Department of Health and Human Services | ISV - INTERNATIONAL SOCIETY FOR VACCINES 2024 ANNUAL CONGRESS - PROJECT SUMMARY / ABSTRACT THE INTERNATIONAL SOCIETY FOR VACCINES (ISV) IS A NOT-FOR-PROFIT MEMBERSHIP ORGANIZATION FOUNDED IN 1992 WITH MEMBERS AND DELEGATES FROM 47 COUNTRIES, HOLDING ANNUAL CONGRESSES SINCE 2007. THE ISV ANNUAL CONGRESS IS THE WORLD’S LARGEST NON-COMMERCIAL SCIENTIFIC CONFERENCE FOR RESEARCHERS INTERESTED IN VACCINES AND IMMUNOTHERAPEUTICS AND THE UNDERLYING SCIENCES. THE TOPICS INCLUDE PROPHYLACTIC AND THERAPEUTIC VACCINES OF INFECTIOUS AND CHRONIC DISEASES AND CANCER, AND HUMAN AND ANIMAL VACCINES, INCLUDING THE INTERSECTION OF ONE HEALTH. PRESENTATIONS COVER BASIC RESEARCH THROUGH MANUFACTURING AND CLINICAL TRIALS. ISV INTENTIONALLY ROTATES THE SITES OF THE MEETINGS BETWEEN ASIA, NORTH AMERICA, AND EUROPE, IN ACCESSIBLE LOCATIONS FOR STRONG REGIONAL AND INTERNATIONAL REPRESENTATION. ISV ATTRACTS RENOWNED LEADERS IN VACCINE FIELDS WHILE SIMULTANEOUSLY PROVIDING OPPORTUNITIES FOR SCIENTISTS FROM LOW- AND MIDDLE-INCOME COUNTRIES (LMICS) TO ATTEND BOTH VIRTUALLY AND IN PERSON, AND FOR STUDENTS AND EARLY CAREER RESEARCHERS (ECRS) TO PRESENT AND GAIN PERSONALIZED FEEDBACK AND MENTORING BY SENIOR SCIENTISTS. ISV IS PARTICULARLY COMMITTED TO ENSURING PARTICIPATION OF FEMALE, UNDERREPRESENTED, AND JUNIOR INVESTIGATORS. THE 2024 ISV ANNUAL CONGRESS, TO BE HELD IN SEOUL, SOUTH KOREA, AIMS TO HIGHLIGHT THE VERY LATEST GROUND-BREAKING DEVELOPMENTS IN VACCINE RESEARCH, MANUFACTURING, CLINICAL DEVELOPMENT AND IMPLEMENTATION, AND SAFETY. PLENARY AND PARALLEL SESSIONS ARE DEVOTED TO CURRENT HOT TOPICS SPANNING DIVERSE AREAS OF VACCINOLOGY. POSTER SESSIONS WILL ALLOW MORE FREE AND DIVERSE SCIENTIFIC EXCHANGE OF EARLY RESEARCH FINDINGS. FUNDING FROM NIAID R13 CONFERENCE GRANT MECHANISM WILL PROVIDE CRITICAL SUPPORT TO LMIC DELEGATES AND STUDENTS IN VACCINOLOGY. | $7,000 | FY2024 | Jul 2024 – Jun 2025 |
| Department of Health and Human Services | 2023 INTERNATIONAL SOCIETY FOR VACCINES (ISV) ANNUAL CONGRESS, OCTOBER 22-25, LAUSANNE, SWITZERLAND - PROJECT SUMMARY / ABSTRACT THE INTERNATIONAL SOCIETY FOR VACCINES (ISV) IS A NOT-FOR-PROFIT MEMBERSHIP ORGANIZATION FOUNDED IN 1992 WITH MEMBERS FROM 44 COUNTRIES, HOLDING ANNUAL CONGRESSES SINCE 2007. WITH THE ISV ANNUAL CONGRESS, ATTENDED BY MEMBER AND NON-MEMBER PARTICIPANTS FROM 5 CONTINENTS, THE SOCIETY AIMS TO HIGHLIGHT THE VERY LATEST GROUND-BREAKING DEVELOPMENTS IN VACCINE RESEARCH, MANUFACTURING, CLINICAL DEVELOPMENT AND IMPLEMENTATION, AND SAFETY. PLENARY SESSIONS ARE DEVOTED TO CURRENT HOT TOPICS SPANNING DIVERSE AREAS OF VACCINOLOGY, INCLUDING VACCINES AGAINST CHALLENGING TARGETS, T-CELL BASED VACCINES, B CELL MEMORY ESTABLISHMENT, STRUCTURE-BASED VACCINE DESIGN, MUCOSAL VACCINES, AND VACCINES AGAINST EMERGING INFECTIOUS DISEASES. THE ISV CONGRESS, AS THE MAIN COMPREHENSIVE NON-COMMERCIAL VACCINE MEETING, STRIVES TO ENSURE PARTICIPATION OF SPEAKERS AND DELEGATES FROM A DIVERSE BACKGROUND (ACADEMIC, INDUSTRY, GOVERNMENT, AND FOUNDATIONS). BREAKOUT SESSIONS INCLUDE TOPICS RELATED TO ADJUVANT MECHANISMS, ONE HEALTH, VACCINES AGAINST ZOONOTIC INFECTIONS, AND NEXT GENERATION VACCINES. RENOWNED INVITED SPEAKERS IN THESE FIELDS HAVE BEEN AND WILL BE INVITED TO SET THE STAGE FOR EACH OF THE PLENARY TOPICS, COMPLEMENTED WITH ORAL PRESENTATIONS SELECTED FROM THE SUBMITTED ABSTRACTS. THE PROGRAM WILL ALSO PROVIDE A FORUM FOR THE NEXT GENERATION OF SCIENTISTS WHO ARE ACTIVE IN THE VACCINOLOGY FIELD, TO PRESENT THEIR DATA IN ORAL OR POSTER PRESENTATIONS, DISCUSS WITH PEERS AND SENIOR SCIENTISTS, AND ADVANCE THEIR CAREERS, BE IT IN ACADEMIA, INDUSTRY, OR GOVERNMENT. ISV’S BRIGHT SPARKS IN VACCINOLOGY COMPETITION ACKNOWLEDGES STUDENT AND POSTDOC PRESENTATIONS IN PARALLEL SESSIONS OF THE ORAL PROGRAM TO SUPPORT THE PARTICIPATION AND CAREERS OF NEXT GENERATION VACCINOLOGISTS. TO STRENGTHEN THEIR PROFESSIONAL ADVANCEMENTS, THE ISV CONGRESS, BUILDING ON ITS LONG-STANDING COMMITMENT TO MENTORING, DEDICATE A SESSION TO CAREER DEVELOPMENT OPPORTUNITIES, BRINGING TOGETHER JUNIOR AND SENIOR SCIENTISTS IN AN INTERACTIVE ATMOSPHERE. TO STIMULATE THE PARTICIPATION OF YOUNG SCIENTISTS, WHICH HAS ALWAYS BEEN SUCCESSFUL IN THE PAST, THE ISV HAS A POLICY OF INEXPENSIVE REGISTRATION RATES FOR PHD STUDENTS AND PROVIDES TRAVEL AWARDS TO SELECTED JUNIOR SCIENTISTS (BASED UPON ABSTRACT SUBMISSION AND REVIEW FOR QUALITY) TO HELP DEFRAY COSTS OF IN-PERSON AND VIRTUAL PARTICIPATION. PRIZES FOR BEST PRESENTATIONS OR ORAL ABSTRACTS AND POSTER ABSTRACTS ARE A HIGH PRIORITY OF THE ISV OFFICERS, WHO VOLUNTEER TO REVIEW AND RANK ALL PRESENTATIONS DURING THE ONGOING CONFERENCE TO SELECT WINNERS AND RUNNERS UP BASED ON ABSTRACT QUALITY AND PRESENTATION SKILLS, AND PRESENT AWARD CERTIFICATES TO THE PRIZE WINNERS. | $5,000 | FY2023 | Aug 2023 – Jul 2024 |
Department of Health and Human Services
$7,000
ISV - INTERNATIONAL SOCIETY FOR VACCINES 2024 ANNUAL CONGRESS - PROJECT SUMMARY / ABSTRACT THE INTERNATIONAL SOCIETY FOR VACCINES (ISV) IS A NOT-FOR-PROFIT MEMBERSHIP ORGANIZATION FOUNDED IN 1992 WITH MEMBERS AND DELEGATES FROM 47 COUNTRIES, HOLDING ANNUAL CONGRESSES SINCE 2007. THE ISV ANNUAL CONGRESS IS THE WORLD’S LARGEST NON-COMMERCIAL SCIENTIFIC CONFERENCE FOR RESEARCHERS INTERESTED IN VACCINES AND IMMUNOTHERAPEUTICS AND THE UNDERLYING SCIENCES. THE TOPICS INCLUDE PROPHYLACTIC AND THERAPEUTIC VACCINES OF INFECTIOUS AND CHRONIC DISEASES AND CANCER, AND HUMAN AND ANIMAL VACCINES, INCLUDING THE INTERSECTION OF ONE HEALTH. PRESENTATIONS COVER BASIC RESEARCH THROUGH MANUFACTURING AND CLINICAL TRIALS. ISV INTENTIONALLY ROTATES THE SITES OF THE MEETINGS BETWEEN ASIA, NORTH AMERICA, AND EUROPE, IN ACCESSIBLE LOCATIONS FOR STRONG REGIONAL AND INTERNATIONAL REPRESENTATION. ISV ATTRACTS RENOWNED LEADERS IN VACCINE FIELDS WHILE SIMULTANEOUSLY PROVIDING OPPORTUNITIES FOR SCIENTISTS FROM LOW- AND MIDDLE-INCOME COUNTRIES (LMICS) TO ATTEND BOTH VIRTUALLY AND IN PERSON, AND FOR STUDENTS AND EARLY CAREER RESEARCHERS (ECRS) TO PRESENT AND GAIN PERSONALIZED FEEDBACK AND MENTORING BY SENIOR SCIENTISTS. ISV IS PARTICULARLY COMMITTED TO ENSURING PARTICIPATION OF FEMALE, UNDERREPRESENTED, AND JUNIOR INVESTIGATORS. THE 2024 ISV ANNUAL CONGRESS, TO BE HELD IN SEOUL, SOUTH KOREA, AIMS TO HIGHLIGHT THE VERY LATEST GROUND-BREAKING DEVELOPMENTS IN VACCINE RESEARCH, MANUFACTURING, CLINICAL DEVELOPMENT AND IMPLEMENTATION, AND SAFETY. PLENARY AND PARALLEL SESSIONS ARE DEVOTED TO CURRENT HOT TOPICS SPANNING DIVERSE AREAS OF VACCINOLOGY. POSTER SESSIONS WILL ALLOW MORE FREE AND DIVERSE SCIENTIFIC EXCHANGE OF EARLY RESEARCH FINDINGS. FUNDING FROM NIAID R13 CONFERENCE GRANT MECHANISM WILL PROVIDE CRITICAL SUPPORT TO LMIC DELEGATES AND STUDENTS IN VACCINOLOGY.
Department of Health and Human Services
$5,000
2023 INTERNATIONAL SOCIETY FOR VACCINES (ISV) ANNUAL CONGRESS, OCTOBER 22-25, LAUSANNE, SWITZERLAND - PROJECT SUMMARY / ABSTRACT THE INTERNATIONAL SOCIETY FOR VACCINES (ISV) IS A NOT-FOR-PROFIT MEMBERSHIP ORGANIZATION FOUNDED IN 1992 WITH MEMBERS FROM 44 COUNTRIES, HOLDING ANNUAL CONGRESSES SINCE 2007. WITH THE ISV ANNUAL CONGRESS, ATTENDED BY MEMBER AND NON-MEMBER PARTICIPANTS FROM 5 CONTINENTS, THE SOCIETY AIMS TO HIGHLIGHT THE VERY LATEST GROUND-BREAKING DEVELOPMENTS IN VACCINE RESEARCH, MANUFACTURING, CLINICAL DEVELOPMENT AND IMPLEMENTATION, AND SAFETY. PLENARY SESSIONS ARE DEVOTED TO CURRENT HOT TOPICS SPANNING DIVERSE AREAS OF VACCINOLOGY, INCLUDING VACCINES AGAINST CHALLENGING TARGETS, T-CELL BASED VACCINES, B CELL MEMORY ESTABLISHMENT, STRUCTURE-BASED VACCINE DESIGN, MUCOSAL VACCINES, AND VACCINES AGAINST EMERGING INFECTIOUS DISEASES. THE ISV CONGRESS, AS THE MAIN COMPREHENSIVE NON-COMMERCIAL VACCINE MEETING, STRIVES TO ENSURE PARTICIPATION OF SPEAKERS AND DELEGATES FROM A DIVERSE BACKGROUND (ACADEMIC, INDUSTRY, GOVERNMENT, AND FOUNDATIONS). BREAKOUT SESSIONS INCLUDE TOPICS RELATED TO ADJUVANT MECHANISMS, ONE HEALTH, VACCINES AGAINST ZOONOTIC INFECTIONS, AND NEXT GENERATION VACCINES. RENOWNED INVITED SPEAKERS IN THESE FIELDS HAVE BEEN AND WILL BE INVITED TO SET THE STAGE FOR EACH OF THE PLENARY TOPICS, COMPLEMENTED WITH ORAL PRESENTATIONS SELECTED FROM THE SUBMITTED ABSTRACTS. THE PROGRAM WILL ALSO PROVIDE A FORUM FOR THE NEXT GENERATION OF SCIENTISTS WHO ARE ACTIVE IN THE VACCINOLOGY FIELD, TO PRESENT THEIR DATA IN ORAL OR POSTER PRESENTATIONS, DISCUSS WITH PEERS AND SENIOR SCIENTISTS, AND ADVANCE THEIR CAREERS, BE IT IN ACADEMIA, INDUSTRY, OR GOVERNMENT. ISV’S BRIGHT SPARKS IN VACCINOLOGY COMPETITION ACKNOWLEDGES STUDENT AND POSTDOC PRESENTATIONS IN PARALLEL SESSIONS OF THE ORAL PROGRAM TO SUPPORT THE PARTICIPATION AND CAREERS OF NEXT GENERATION VACCINOLOGISTS. TO STRENGTHEN THEIR PROFESSIONAL ADVANCEMENTS, THE ISV CONGRESS, BUILDING ON ITS LONG-STANDING COMMITMENT TO MENTORING, DEDICATE A SESSION TO CAREER DEVELOPMENT OPPORTUNITIES, BRINGING TOGETHER JUNIOR AND SENIOR SCIENTISTS IN AN INTERACTIVE ATMOSPHERE. TO STIMULATE THE PARTICIPATION OF YOUNG SCIENTISTS, WHICH HAS ALWAYS BEEN SUCCESSFUL IN THE PAST, THE ISV HAS A POLICY OF INEXPENSIVE REGISTRATION RATES FOR PHD STUDENTS AND PROVIDES TRAVEL AWARDS TO SELECTED JUNIOR SCIENTISTS (BASED UPON ABSTRACT SUBMISSION AND REVIEW FOR QUALITY) TO HELP DEFRAY COSTS OF IN-PERSON AND VIRTUAL PARTICIPATION. PRIZES FOR BEST PRESENTATIONS OR ORAL ABSTRACTS AND POSTER ABSTRACTS ARE A HIGH PRIORITY OF THE ISV OFFICERS, WHO VOLUNTEER TO REVIEW AND RANK ALL PRESENTATIONS DURING THE ONGOING CONFERENCE TO SELECT WINNERS AND RUNNERS UP BASED ON ABSTRACT QUALITY AND PRESENTATION SKILLS, AND PRESENT AWARD CERTIFICATES TO THE PRIZE WINNERS.
Source: Federal Audit Clearinghouse (fac.gov)
No federal single audit records found for this organization.
Single audits are required for entities expending $750,000+ in federal awards annually.
Source: IRS e-Filed Form 990
No officer or director compensation data available for this organization.
This data is sourced from IRS Form 990, Part VII. It may not be available if the organization files Form 990-N (e-Postcard) or has not yet been enriched.
Source: IRS Publication 78, Auto-Revocation List & e-Postcard Data
Tax-deductible contributions: Yes
Deductibility code: PC
Sources: IRS e-Filed Form 990 (XML) & ProPublica Nonprofit Explorer
Scroll →
| Year | Revenue | Contributions | Expenses | Assets | Net Assets |
|---|---|---|---|---|---|
| 2023 | $559.3K | $63K | $495.2K | $350.1K | $350.1K |
| 2022 | $250.6K | $10K | $266.6K | $442K | $286K |
| 2021 | $137.4K | $0 | $79.3K | $302K | $302K |
| 2020 | $49.2K | $0 | $75.2K | $243.9K |
Sources: ProPublica Nonprofit Explorer & IRS e-File Index
| Tax Year | Form Type | Source | Documents |
|---|---|---|---|
| 2024 | 990 | IRS e-File | PDF not yet published by IRSView Filing → |
| 2023 | 990 | DataIRS e-File | PDF not yet published by IRSView Filing → |
| 2022 | 990 | DataIRS e-File |
Financial data: IRS Form 990 via ProPublica Nonprofit Explorer (Tax Year 2023)
Federal grants: USAspending.gov (live)
Organization info: IRS Business Master File · ProPublica Nonprofit Explorer
Tax-deductibility: IRS Publication 78
| $243.9K |
| 2019 | $393.3K | $20K | $295K | $269.9K | $269.9K |
| 2018 | $271.6K | $20K | $324.8K | $171.6K | $171.6K |
| 2017 | $331.6K | $146.5K | $250.1K | $224.8K | $224.8K |
| 2016 | $349.3K | $193.8K | $254.8K | $143.3K | $143.3K |
| 2015 | $16.7K | — | $27.6K | $48.7K | — |
| 2014 | $28.7K | — | $13.1K | $59.7K | — |
| 2013 | $15.9K | — | $50.7K | $44.1K | — |
| 2012 | $68.3K | — | $9,267 | $78.8K | — |
| 2021 | 990 | Data |
| 2020 | 990 | Data |
| 2019 | 990 | Data |
| 2018 | 990 | Data |
| 2017 | 990 | Data |
| 2016 | 990 | Data |
| 2015 | 990-EZ | Data |
| 2014 | 990-EZ | Data |
| 2013 | 990-EZ | Data |
| 2012 | 990-EZ | Data |
| 2011 | 990-EZ | — |
| 2010 | 990-EZ | — |